WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Kausar Begam Riaz Ahmed
900 Points

Contributions by role

Editor 900

Contributions by subject area

Oncology
Orthopedics
Surgery and Surgical Specialties
Biochemistry
Toxicology
Drugs and Devices
Pharmacology
Biotechnology
Cell Biology
Microbiology
Infectious Diseases
Gynecology and Obstetrics
Histology
Medical Genetics
Global Health
Nutrition
Public Health
Bioinformatics
Molecular Biology
Respiratory Medicine
Gastroenterology and Hepatology

Kausar Begam Riaz Ahmed


Summary

Dr. Riaz Ahmed is a scientist at the US Food and Drug Administration. Her research focus includes toxicology, pharmacology, computational modeling, drug discovery and development. She has a PhD in Biomedical Sciences from the University of Texas MD Anderson Cancer Center.

Biochemistry Biophysics Biotechnology Computational Biology Computational Science Data Mining & Machine Learning Drugs & Devices Food Science & Technology Mathematical Biology Natural Products Synthetic Biology Toxicology

Work details

Scientist

Food and Drug Administration
Food and Drug Administration

Websites

  • Google Scholar

PeerJ Contributions

  • Edited 5

Academic Editor on

July 7, 2021
Anti-inflammatory and antiaging properties of chlorogenic acid on UV-induced fibroblast cell
Ermi Girsang, Chrismis N. Ginting, I Nyoman Ehrich Lister, Kamila yashfa Gunawan, Wahyu Widowati
https://doi.org/10.7717/peerj.11419 PubMed 34277144
June 9, 2021
Increased microRNA-30a levels in bronchoalveolar lavage fluid as a diagnostic biomarker for lung cancer
Wen-Jun Zhu, Bo-Jiang Chen, Ying-Ying Zhu, Ling Sun, Yu-Chen Zhang, Huan Liu, Feng-Ming Luo
https://doi.org/10.7717/peerj.11528 PubMed 34178448
April 28, 2021
Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma
Lei Yang, Weilong Yin, Xuechen Liu, Fangcun Li, Li Ma, Dong Wang, Hongxing Li
https://doi.org/10.7717/peerj.11273 PubMed 33986994
December 16, 2020
Clinical features and prognostic factors of spinal fibroblastic/myofibroblastic tumors: a long-term, single-center, retrospective study
Haitao Sun, Shaohui He, Yuechao Zhao, Chen Ye, Xinghai Yang, Wei Xu, Jianru Xiao
https://doi.org/10.7717/peerj.10530 PubMed 33362974
November 10, 2020
Differential effects of cotreatment of the antibiotic rifampin with host-directed therapeutics in reducing intracellular Staphylococcus aureus infection
Melissa D. Evans, Robert Sammelson, Susan McDowell
https://doi.org/10.7717/peerj.10330 PubMed 33240647